Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
In this study, we investigated the role of type I interferon (IFN) in the induction of HBV-specific CD8 + T cell responses. In a transient HBV infection model, we showed that type I IFN indirectly attenuates HBV-specific CD8 + T cell response by suppressing the amount of antigen in the early stage of HBV transduction. On the other hand, in the persistent HBV infection model, we showed that antigen recognition in the liver suppresses the type I IFN signal in CD8 + T cells, and that its activation is extremely important for the induction of T cell proliferation and functionality
|